Non-viral methods for gene transfer towards osteosarcoma therapy

References

• Barzon L, Stefani AL, Pacenti M, Palu G. Versatility of gene therapy vectors through viruses. Expert Opin Biol Ther 2005; 5(5)639–662
   PubMed Web of Science ®Google Scholar
• Benjamin R, Helman L, Meyers P, Reaman G. A phase I/II dose escalation and activity study of intravenous injections of OCaP1 for subjects with refractory osteosarcoma metastatic to lung. Hum Gene Ther 2001; 12(12)1591–1593
   PubMedGoogle Scholar
• Cheon J, Ko SC, Gardner TA, Shirakawa T, Gotoh A, Kao C, Chung LW. Chemogene therapy: Osteocalcin promoter-based suicide gene therapy in combination with methotrexate in a murine osteosarcoma model. Cancer Gene Ther 1997; 4(6)359–365
   PubMed Web of Science ®Google Scholar
• Cichutek K. Lessons learned from gene therapy concerning and the use of integrating vectors and the possible risk of insertional oncogenesis. Dev Biol (Basel) 2006; 123: 29–34
   PubMedGoogle Scholar
• Dass CR. Cationic liposomes and gene therapy for solid tumors. Drug Delivery 1997; 4: 151–165
   Web of Science ®Google Scholar
• Dass CR. Vehicles for oligonucleotide delivery to tumours. J Pharm Pharmacol 2002; 54: 3–27
   PubMed Web of Science ®Google Scholar
• Dass CR. Oligonucleotide delivery to tumours using macromolecular carriers. Biotechnol Appl Biochem 2004a; 40(Pt 2)113–122
   PubMedGoogle Scholar
• Dass CR. Cyclodextrins and oligonucleotide delivery to solid tumours. J Drug Target 2004b; 12(1)1–9
   PubMed Web of Science ®Google Scholar
• Dass CR. Preclinical anticancer activity of DNA-based cleavage molecules. Drug Dev Ind Pharm 2006; 32(1)1–5
   PubMed Web of Science ®Google Scholar
• Dass CR, Burton MA. A model for evaluating selective delivery of plasmid DNA to tumours via the vasculature. Cancer Biother Radiopharm 2002; 17(5)501–505
   PubMed Web of Science ®Google Scholar
• Dass CR, Burton MA. Modified microplex vector enhances transfection of cells in culture while maintaining tumour-selective gene delivery in-vivo. J Pharm Pharmacol 2003; 55(1)19–25
   PubMed Web of Science ®Google Scholar
• Dass CR, Choong PF. Selective gene delivery for cancer therapy using cationic liposomes: In vivo proof of applicability. J Control Release 2006a; 113(2)155–163
   PubMed Web of Science ®Google Scholar
• Dass CR, Choong PF. Carrier-mediated delivery of peptidic drugs for cancer therapy. Peptides 2006b, epub ahead of print
   Web of Science ®Google Scholar
• Dass CR, Choong PF. Biophysical delivery of peptides: Applicability for cancer therapy. Peptides 2006c, epub ahead of print
   Web of Science ®Google Scholar
• Dass CR, Saravolac EG, Li Y, Sun LQ. Cellular uptake, distribution, and stability of 10–23 deoxyribozymes. Antisense Nucleic Acid Drug Dev 2002; 12(5)289–299
   PubMedGoogle Scholar
• Dass CR, Nadesapillai AP, Robin D, Howard ML, Fisher JL, Zhou H, Choong PF. Downregulation of uPAR confirms link in growth and metastasis of osteosarcoma. Clin Exp Metastasis 2005; 22(8)643–652
   PubMed Web of Science ®Google Scholar
• Dass CR, Ek ET, Choong PF. Human xenograft osteosarcoma models with spontaneous metastasis in mice: Clinical relevance and applicability for drug testing. J Cancer Res Clin Oncol 2006a; 132, in press
   Google Scholar
• Dass CR, Ek ET, Contreras KG, Choong PF. A novel orthotopic murine model provides insights into cellular and molecular characteristics contributing to human osteosarcoma. Clin Exp Metastasis 2006b; 23, in press
   Google Scholar
• Densmore CL, Kleinerman ES, Gautam A, Jia SF, Xu B, Worth LL, Waldrep JC, Fung YK, T'Ang A, Knight V. Growth suppression of established human osteosarcoma lung metastases in mice by aerosol gene therapy with PEI-p53 complexes. Cancer Gene Ther 2001; 8(9)619–627
   PubMed Web of Science ®Google Scholar
• Duan X, Jia SF, Koshkina N, Kleinerman ES. Intranasal interleukin-12 gene therapy enhanced the activity of ifosfamide against osteosarcoma lung metastases. Cancer 2006; 106(6)1382–1388
   PubMed Web of Science ®Google Scholar
• Dutour A, Rabinovich-Chable H, Kaletta C, Michaelis U, Fiorenza F, Sturtz F, Rigaud M. Is troponin I gene therapy effective for osteosarcoma treatment? Study on a human-like orthotopic rat model. Anticancer Res 2004; 24(6)3977–3982
   PubMed Web of Science ®Google Scholar
• Dutour A, Monteil J, Paraf F, Charissoux JL, Kaletta C, Sauer B, Naujoks K, Rigaud M. Endostatin cDNA/cationic liposome complexes as a promising therapy to prevent lung metastases in osteosarcoma: Study in a human-like rat orthotopic tumor. Mol Ther 2005; 11(2)311–319
   PubMed Web of Science ®Google Scholar
• Ek ET, Choong PF. The role of high-dose therapy and autologous stem cell transplantation for pediatric bone and soft tissue sarcomas. Expert Rev Anticancer Ther 2006; 6(2)225–237
   PubMed Web of Science ®Google Scholar
• Fahmy RG, Dass CR, Sun LQ, Chesterman CN, Khachigian LM. Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth. Nat Med 2003; 9(8)1026–1032
   PubMed Web of Science ®Google Scholar
• Felgner PL, Gadek TR, Holm M, Roman R, Chan HW, Wenz M, Northrop JP, Ringold GM, Danielsen M. Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci USA 1987; 84(21)7413–7417, November
   PubMed Web of Science ®Google Scholar
• Fisher JL, Mackie PS, Howard ML, Zhou H, Choong PF. The expression of the urokinase plasminogen activator system in metastatic murine osteosarcoma: An in vivo mouse model. Clin Cancer Res 2001; 7(6)1654–1660
   PubMed Web of Science ®Google Scholar
• Jia SF, Worth LL, Kleinerman ES. A nude mouse model of human osteosarcoma lung metastases for evaluating new therapeutic strategies. Clin Exp Metastasis 1999; 17(6)501–506
   PubMed Web of Science ®Google Scholar
• Jia SF, Worth LL, Densmore CL, Xu B, Zhou Z, Kleinerman ES. Eradication of osteosarcoma lung metastases following intranasal interleukin-12 gene therapy using a nonviral polyethylenimine vector. Cancer Gene Ther 2002; 9(3)260–266
   PubMed Web of Science ®Google Scholar
• Khan AU. Ribozyme: A clinical tool. Clin Chim Acta 2006; 367(1–2)20–27
   PubMed Web of Science ®Google Scholar
• Lachman HM, Cheng GH, Skoultchi AI. Transfection of mouse erythroleukemia cells with myc sequences changes the rate of induced commitment to differentiate. Proc Natl Acad Sci USA 1986; 83(17)6480–6484
   PubMed Web of Science ®Google Scholar
• Link MP, Goorin AM, Miser AW, et al. The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med 1986; 314(25)1600–1606
   PubMed Web of Science ®Google Scholar
• Longhi A, Errani C, De Paolis M, Mercuri M, Bacci G. Primary bone osteosarcoma in the pediatric age: State of the art. Cancer Treat Rev 2006; 32(6)423–436
   PubMed Web of Science ®Google Scholar
• Luu HH, Kang Q, Park JK, Si W, Luo Q, Jiang W, Yin H, Montag AG, Simon MA, Peabody TD, Haydon RC, Rinker-Schaeffer CW, He TC. An orthotopic model of human osteosarcoma growth and spontaneous pulmonary metastasis. Clin Exp Metastasis 2005; 22(4)319–329
   PubMed Web of Science ®Google Scholar
• Nimjee SM, Rusconi CP, Sullenger BA. Aptamers: An emerging class of therapeutics. Annu Rev Med 2005; 56: 555–583
   PubMed Web of Science ®Google Scholar
• Putral LN, Gu W, McMillan NA. RNA interference for the treatment of cancer. Drug News Perspect 2006; 19(6)317–324
   PubMed Web of Science ®Google Scholar
• Thomas M, Ge Q, Lu JJ, Chen J, Klibanov AM. Cross-linked small polyethylenimines: While still nontoxic, deliver DNA efficiently to mammalian cells in vitro and in vivo. Pharm Res 2005; 22(3)373–380
   PubMed Web of Science ®Google Scholar
• Wacheck V, Zangemeister-Wittke U. Antisense molecules for targeted cancer therapy. Crit Rev Oncol Hematol 2006; 59(1)65–73, July
   PubMed Web of Science ®Google Scholar
• Walker TL, Dass CR, Burton MA. Enhanced in vivo tumour response from combination of carboplatin and low-dose c-myc antisense oligonucleotides. Anticancer Res 2002; 22(4)2237–2245
   PubMed Web of Science ®Google Scholar
• Witlox MA, Lamfers ML, Wuisman PI, Curiel DT, Siegal GP. Evolving gene therapy approaches for osteosarcoma using viral vectors: Review. Bone 2006, December 22, [Epub ahead of print]
   PubMed Web of Science ®Google Scholar